Financial Architects, Inc Cara Therapeutics, Inc. Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$12.34 - $17.92 $2,468 - $3,584	-200 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$14.41 - $19.64 $2,882 - $3,928	200 New	200 $4,000
Q4 2018 Feb 01, 2019	SELL	$12.45 - $23.47 $6,225 - $11,735	-500 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$11.6 - $19.27 $5,800 - $9,635	500 New	500 $10,000

885K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $271M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.